Sanofi Sues Apotex Over Cancer Treatment
Apotex Inc. infringed two patents when it sought regulatory approval to tap into the growing U.S. market for the cancer treatment Taxotere, according to a complaint filed Friday by French drug...To view the full article, register now.
Already a subscriber? Click here to view full article